Appendicitis Market Research Report - Global Forecast till 2030

Global Appendicitis Market: Information by Type (Acute, Chronic), Diagnosis & Treatment (Diagnosis & Treatment), End User (Hospitals & Clinics, Diagnostic Centers) and Region (North America, Europe, Asia-Pacific & Middle East & Africa) - Forecast till 2030

ID: MRFR/HC/3849-CR | 125 Pages | Published By Rahul Gotadki on August 2019         

Appendicitis Market Speak to Analyst Request a Free Sample


The appendicitis market is projected to reach USD 9547.08 Million by 2030 at 4.10% CAGR during the forecast period 2022-2030

Appendicitis is a common cause of acute abdominal pain. It occurs when the appendix is blocked by stool, foreign body, or cancer. Infection is the leading cause of appendicitis in some patients. Growing geriatric population, rise in incidences of appendicitis, and increasing disease awareness drives the growth of the global appendicitis market. However, stringent regulatory policies are likely hampering market growth. The increasing prevalence of appendicitis, such as acute appendicitis is driving the growth of the global appendicitis market.

Market Dynamics

Appendicitis is the inflammation of the vermiform appendix. The vermiform appendix is a hollow organ which is located at the tip of cecum that is present at the right lower part of the abdomen. This inflammation can occur in almost any area of the abdomen. It is also one of the most common causes of abdominal pain in adults and children. Appendicitis could be diagnosed with the help of physical examination and laboratory studies. It occurs when the appendix is blocked due to a foreign body, cancer, or by stool. The prevalence of acute appendicitis is more as compared to chronic appendicitis. Around 8.6% of men and 6.7% of female worldwide are suffering from acute appendicitis. Computed tomography (CT) is frequently used for the diagnosis of acute appendicitis, and it gives more accurate results as compared to other diagnostic tests. CT plays a main role in the decision-making process in acute appendicitis and is considered as the first-line imaging modality in the diagnosis of acute appendicitis. To overcome this appendicitis appendectomy is considered as the first line treatment. In developing countries, growth in the appendicitis market is propelled by increasing government investments in healthcare. The global appendicitis market is expected to grow due to the increasing prevalence of appendicitis, and rising demand for diagnostic and treatment options of appendicitis.

Global Appendicitis Market Revenue, by Type, 2024 (USD Million)  Appendicitis Market_Image

Sources: MRFR Analysis


The acute segment is expected to lead the market and register a substantial CAGR to reach USD 9,518.69 million by the end of 2024. The acute diagnostic tests are most widely used as there is an increasing the prevalence of the infectious disease across the globe. However, the chronic segment is projected to exhibit the highest CAGR of 3.73% from 2019 to 2024.

Global Appendicitis Market Share, by Region, 2018 (%)     Appendicitis Market          

Sources: MRFR Analysis

Regional Analysis

North America is expected to dominate the market. The market growth in this region is mainly due to the incidence of appendicitis and subsequently increasing awareness regarding the disease and the growing demand for effective treatment methods. North America accounted for the largest market share of 39.8% in 2018, and the regional market is projected to register a CAGR of 4.06% during the forecast period. Latin America is one of the leading markets in the region, accounting for the largest market share during the review period.

The European market is estimated to exceed Substantial value by 2030. Continuous development in molecular diagnostic products and the rising prevalence of infectious disease are driving the growth of the appendicitis market in the region. Italy is the major contributor to the growth of the regional market, followed by the UK.

Key Players

The prominent players in the global appendicitis market are Johnson & Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel)

The players operating in the global appendicitis market are focusing on product launches, along with expanding their global footprints by entering untapped markets.   

Market Segmentation

Global Appendicitis Market, by Type

  • Acute

  • Chronic

Global Appendicitis Market, by Diagnosis & Treatment   

  • Diagnosis

  • Ultrasound Imaging

  • CT Scan

  • Others

  • Treatment

  • Antibiotics

  • Appendectomy

Global Appendicitis Market, by End User

  • Hospitals & Clinics

  • Diagnostic Centers

Global Appendicitis Market, by Region

  • North America

    • US

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia & New Zealand

    • Southeast Asia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • South America

Available Additional Customizations

Company Profiles of Key Regional Players

  • GSK

  • Merck

  • Sanofi

  • McNeil Pharmaceuticals

Intended Audience

  • Retailers, distributors, and wholesalers

  • Governments, associations, and industrial bodies

  • Investors and trade experts

  • Medical device manufacturers

  • Medical device suppliers

  • Medical research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors


Report Scope:

Report Attribute/Metric Details
  Market Size   USD 9547.08 Million
  CAGR   4.10%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis & Treatment, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Johnson & Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel)
  Key Market Opportunities   Entering Developing Economies
  Key Market Drivers

  • Increasing Prevalence Of Acute Appendicitis
  • Rising Demand For Diagnostic And Treatment Options Of Appendicitis

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Appendicitis market projected to grow at approximately 4.10% CAGR during the assessment period (2022-2030).

    The valuation of the global Appendicitis market is estimated to increase to USD 9547.08 Million by the end of 2030.

    Rising prevealnce and advancements in the treatment procedures are major tailwinds pushing the growth of the global Appendicitis market.

    North America holds the largest share in the global Appendicitis market, followed by Europe and the Asia Pacific, respectively.

    Pfizer Inc. (US), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Medtronic (Ireland), Cook (US), are some of the top players operating in the global Appendicitis market.